• OPEN AN ACCOUNT
Indian Indices
Sensex
74,314.59 -21.86
( -0.03%)
Global Indices
Nasdaq
51,493.09 -621.02
(-1.19%)
Dow Jones
7,573.47 -33.26
(-0.44%)
Hang Seng
63,960.24 37.24
(0.06%)
Nikkei 225
10,694.45 36.32
(0.34%)
Forex
USD-INR
95.42 0.14
(0.14%)
EUR-INR
110.10 0.01
(0.01%)
GBP-INR
128.62 0.03
(0.02%)
JPY-INR
0.62 0.00
(-0.26%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
337.9869392
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
43.43
43743.16
EPS(TTM)
Face Value()
Div & Yield %
80.61
2
0.8
 

swastika investmart ltd
Pritika Engineering Components consolidated net profit declines 21.39% in the March 2026 quarter
May 23,2026
Net profit of Pritika Engineering Components declined 21.39% to Rs 1.36 crore in the quarter ended March 2026 as against Rs 1.73 crore during the previous quarter ended March 2025. Sales rose 41.28% to Rs 48.36 crore in the quarter ended March 2026 as against Rs 34.23 crore during the previous quarter ended March 2025.

For the full year,net profit rose 27.35% to Rs 7.31 crore in the year ended March 2026 as against Rs 5.74 crore during the previous year ended March 2025. Sales rose 37.90% to Rs 161.87 crore in the year ended March 2026 as against Rs 117.38 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales48.3634.23 41 161.87117.38 38
OPM %10.0114.37 -13.2915.56 -
PBDT3.493.78 -8 15.7713.11 20
PBT1.652.17 -24 8.837.22 22
NP1.361.73 -21 7.315.74 27